Homebiotech

biotech

biotech

New norovirus vaccine approach may help treat other RNA viruses

Jim Cornall - August 25, 2026

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026

biotech

KTU chemists develop dual-action compounds to fight cancer

Jim Cornall - August 20, 2026

biotech

RSV antiviral drug receives FDA approval for phase II trial

Jim Cornall - August 20, 2026

biotech

Brain tau spreads differently in early- and late-onset Alzheimer’s disease

Jim Cornall - June 29, 2026

biotech

Base to Base biotech podcast 65: Giving medicine a genetic camouflage

Jim Cornall - June 26, 2026

biotech

Vedana Therapeutics launches to develop migraine therapies

Jim Cornall - June 25, 2026

biotech

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

Jim Cornall - June 25, 2026

biotech

Meteor Biotech joins brain organoids consortium

Jim Cornall - June 25, 2026

biotech

Can food influence gene activity?

Jim Cornall - June 24, 2026

biotech

Lab-engineered proteins: a promising treatment for liver disease

Jim Cornall - June 24, 2026

biotech

Insilico Medicine And SK Biopharmaceuticals to collaborate in $2.5bn deal

Jim Cornall - June 24, 2026

1...101112...96 Page 11 of 96

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

New norovirus vaccine approach may help treat other RNA viruses

Jim Cornall - August 25, 2026 0

On a genetic level, RNA viruses share common structural elements. The RNA of their genomes has strings, folds, and knot-like features that interact with...

Base to Base biotech podcast 72: Cell-free DNA bioproduction

biotech Jim Cornall - August 21, 2026 0

KTU chemists develop dual-action compounds to fight cancer

biotech Jim Cornall - August 20, 2026 0

RSV antiviral drug receives FDA approval for phase II trial

biotech Jim Cornall - August 20, 2026 0

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

biotech Jim Cornall - August 19, 2026 0